Two Sigma Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-21,800
Closed -$888K 2556
2019
Q3
$888K Sell
21,800
-10,000
-31% -$432K ﹤0.01% 1492
2019
Q2
$1.53M Buy
31,800
+16,100
+103% +$846K ﹤0.01% 1326
2019
Q1
$983K Buy
15,700
+5,800
+59% +$398K ﹤0.01% 1538
2018
Q4
$591K Buy
9,900
+6,656
+205% +$400K ﹤0.01% 1699
2018
Q3
$209K Buy
+3,244
New +$181K ﹤0.01% 2071
2017
Q3
Sell
-35,644
Closed -$1.19M 2466
2017
Q2
$1.19M Sell
35,644
-80,300
-69% -$2.4M ﹤0.01% 1443
2017
Q1
$3.36M Sell
115,944
-7,994
-6% -$198K 0.01% 994
2016
Q4
$2.77M Buy
123,938
+3,138
+3% +$61.4K 0.01% 1021
2016
Q3
$2.24M Buy
120,800
+109,300
+950% +$2.06M 0.01% 980
2016
Q2
$187K Buy
+11,500
New +$169K ﹤0.01% 1877
2015
Q4
Sell
-11,300
Closed -$138K 2145
2015
Q3
$138K Buy
+11,300
New +$144K ﹤0.01% 1692

Other funds holding BEAT

Two Sigma Advisers's BEAT Position: Q4 2019 in Review

Two Sigma Advisers sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 21,800 shares — an estimated $888K sold.

Two Sigma Advisers first reported a position in BEAT in Q3 2015 and held it in 11 quarters. The position peaked at $3.36M in Q1 2017. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Two Sigma Advisers reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Advisers sold 21,800 BioTelemetry, Inc. shares in Q4 2019, an estimated $888K.
  • Two Sigma Advisers first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 11 quarters.
  • Two Sigma Advisers's BioTelemetry, Inc. position peaked at $3.36M in Q1 2017.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.